Advisornet Financial’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $152K | Sell |
1,682
-271
| -14% | -$22.7K | 0.01% | 727 |
|
|
2026
Q1 | $156K | Buy |
1,953
+13
| +0.7% | +$1.07K | 0.01% | 679 |
|
|
2025
Q4 | $165K | Buy |
1,940
+267
| +16% | +$21.9K | 0.01% | 653 |
|
|
2025
Q3 | $130K | Buy |
1,673
+12
| +0.7% | +$938 | 0.01% | 713 |
|
|
2025
Q2 | $130K | Sell |
1,661
-2
| -0.1% | -$149 | 0.01% | 684 |
|
|
2025
Q1 | $121K | Buy |
1,663
+172
| +12% | +$12.3K | 0.01% | 674 |
|
|
2024
Q4 | $110K | Sell |
1,491
-341
| -19% | -$23.9K | 0.01% | 656 |
|
|
2024
Q3 | $121K | Sell |
1,832
-192
| -9% | -$13.9K | 0.01% | 649 |
|
|
2024
Q2 | $187K | Hold |
2,024
| – | – | 0.02% | 491 |
|
|
2024
Q1 | $193K | Sell |
2,024
-94
| -4% | -$7.9K | 0.02% | 480 |
|
|
2023
Q4 | $161K | Buy |
2,118
+273
| +15% | +$19K | 0.01% | 519 |
|
|
2023
Q3 | $128K | Buy |
1,845
+58
| +3% | +$4.66K | 0.01% | 549 |
|
|
2023
Q2 | $169K | Sell |
1,787
-46
| -3% | -$4K | 0.01% | 515 |
|
|
2023
Q1 | $152K | Buy |
1,833
+188
| +11% | +$14.8K | 0.01% | 520 |
|
|
2022
Q4 | $123K | Buy |
1,645
+51
| +3% | +$3.93K | 0.01% | 578 |
|
|
2022
Q3 | $132K | Sell |
1,594
-180
| -10% | -$17.3K | 0.01% | 591 |
|
|
2022
Q2 | $169K | Sell |
1,774
-125
| -7% | -$12.9K | 0.02% | 545 |
|
|
2022
Q1 | $224K | Buy |
1,899
+252
| +15% | +$28.3K | 0.01% | 534 |
|
|
2021
Q4 | $213K | Sell |
1,647
-112
| -6% | -$13.1K | 0.01% | 589 |
|
|
2021
Q3 | $199K | Buy |
1,759
+775
| +79% | +$88.5K | 0.01% | 585 |
|
|
2021
Q2 | $102K | Hold |
984
| – | – | 0.01% | 781 |
|
|
2021
Q1 | $82K | Hold |
984
| – | – | 0.01% | 806 |
|
|
2020
Q4 | $90K | Sell |
984
-58
| -6% | -$4.81K | 0.01% | 721 |
|
|
2020
Q3 | $83K | Sell |
1,042
-86
| -8% | -$6.71K | 0.01% | 722 |
|
|
2020
Q2 | $78K | Buy |
1,128
+129
| +13% | +$9.17K | 0.01% | 742 |
|
|
2020
Q1 | $63K | Hold |
999
| – | – | 0.01% | 729 |
|
|
2019
Q4 | $78K | Hold |
999
| – | – | 0.01% | 753 |
|
|
2019
Q3 | $73K | Buy |
999
+285
| +40% | +$20K | 0.01% | 775 |
|
|
2019
Q2 | $44K | Hold |
714
| – | – | ﹤0.01% | 837 |
|
|
2019
Q1 | $46K | Hold |
714
| – | – | 0.01% | 754 |
|
|
2018
Q4 | $36K | Hold |
714
| – | – | 0.01% | 761 |
|
|
2018
Q3 | $41K | Sell |
714
-36
| -5% | -$1.76K | 0.01% | 781 |
|
|
2018
Q2 | $36K | Buy |
750
+93
| +14% | +$4.34K | ﹤0.01% | 798 |
|
|
2018
Q1 | $31K | Hold |
657
| – | – | ﹤0.01% | 823 |
|
|
2017
Q4 | $25K | Buy |
+657
| New | +$24.1K | ﹤0.01% | 816 |
|
Other funds holding EW
Advisornet Financial's EW Position: Q2 2026 in Review
Advisornet Financial reduced its Edwards Lifesciences (EW) stake by 14% in Q2 2026, selling an estimated $22.7K and leaving 1,682 shares worth $152K. The position accounts for 0.01% of the portfolio, ranked #727.
Advisornet Financial first reported a position in EW in Q4 2017 and has held it in 35 quarters since. The position peaked at $224K in Q1 2022. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Advisornet Financial held 1,682 shares of Edwards Lifesciences worth $152K as of Q2 2026.
- Advisornet Financial sold 271 Edwards Lifesciences shares in Q2 2026, an estimated $22.7K.
- Edwards Lifesciences made up 0.01% of Advisornet Financial's portfolio in Q2 2026, its #727 holding.
- Advisornet Financial first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Edwards Lifesciences position peaked at $224K in Q1 2022.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.